Announced details
The company conducted research and development with Durham University in the UK. The main text also states that the Group’s European CSO at リプロセル is a professor of cell engineering at the university.
Durham University in the UK. The main text indicates a research and development relationship with a professor of cell engineering, but does not provide the university’s location, stated capital or year established.
The impact on current-period results is expected to be minor at this time. The company will promptly disclose any matters that arise requiring disclosure.
The company does not address Contract Value / Offering price.
| Item | Details |
|---|---|
| Names of Products / Services Covered | REPROSKIN™ |
| Counterparty | Durham University in the UK |
| Counterparty overview | Durham University in the UK. The main text indicates a research and development relationship with a professor of cell engineering, but does not provide the university’s location, stated capital or year established. |
| Relationship with the Company | The company conducted research and development with Durham University in the UK. The main text also states that the Group’s European CSO at リプロセル is a professor of cell engineering at the university. |
| Launch date | 9 October 2026 (sales already launched) |
| Applicable area | Skin disease research, Wound healing research, Pigmentation research, Skin aging research, Drug Discovery, Preclinical studies, Safety assessment, Skin biology research, Skincare research |
| Impact on Business Performance | The impact on current-period results is expected to be minor at this time. The company will promptly disclose any matters that arise requiring disclosure. |
Items this document does not state (11)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The product was developed through research and development using Alvetex® technology, a proprietary three-dimensional culture technology, in collaboration with Durham University in the UK, to replicate the structural and biological characteristics of human skin.